Replies to post #67646 on Biotech Values

[masterlongevity]

"The efficacy in crohns is outstanding. "

this is debatable. unlike MS, Tysabri efficacy is Crohn's in not more effective than otehr therapies.

Keep in mind that the non-carrier analysis in the ph 2 only included 9 pts per arm